Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05752955
Other study ID # 27-21
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 6, 2022
Est. completion date December 2024

Study information

Verified date February 2023
Source The George Institute
Contact Eldho Baslin Rajan, Msc Nursing
Phone +914030994444
Email erajan@georgeinstitute.org.in
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to determine if a complex intervention called SMARThealth Pregnancy can improve the detection and management of high-risk conditions during pregnancy and in the first year after birth in women living in rural India. The main questions it aims to answer are: - Can screening of pregnant and postpartum women using the SMARThealth Pregnancy intervention decrease anaemia prevalence at 1 year after birth? - Can the SMARThealth Pregnancy intervention improve postnatal testing after a pregnancy affected by hypertension and diabetes? Participants in the intervention group will be screened by their community health worker at several timepoints during pregnancy, and in the first year after birth using the SMARThealth Pregnancy tablet App. The community health worker will ask about each woman about her medical and obstetric history, then measure her blood pressure, haemoglobin (using a point of care device), and offer a referral for a glucose tolerance test when indicated. Women who screen positive for anaemia, hypertension or diabetes will be given advice and referred to the primary care doctor. The primary care doctor will have a complimentary tablet app to facilitate electronic referral and evidence-based prescribing when indicated. The comparison group will have usual antenatal and postnatal care.


Description:

The primary aim of this study is to determine if the SMARThealth Pregnancy intervention can improve women's health in the year after pregnancy, specifically decrease the prevalence of anaemia by 9% and improve follow-up after a pregnancy affected by diabetes or hypertension. High glucose and blood pressure are the two leading contributors to cardiometabolic risk in women in India, thus it is hypothesised that targeting women identified in pregnancy at high risk of these conditions future risk can be decreased. This study hypothesize SMARThealth Pregnancy intervention will: - Decrease anaemia prevalence by 9% in women at 12 months after delivery by improving adherence to the current national government guidelines for iron folic acid supplementation through behavioural change interventions delivered to the woman by the Community Health Worker (CHW): (i) during pregnancy, with referral for iron sucrose injections where indicated; and, (ii) during breastfeeding, and (iii) after breastfeeding. - Ensure women who develop gestational diabetes mellitus (GDM) are identified during pregnancy with appropriate referral, and followed up after birth and screened for the development of type 2 diabetes. - Detect women with raised blood pressure during pregnancy, and provide ongoing periodic blood pressure (BP) monitoring after birth to detect ongoing hypertension. - Provide all women during pregnancy and after birth regular mental health assessment and support leading to improved mental state and wellbeing - Ensure after birth women are offered and have access to appropriate contraception choices - Improve communication between different levels of the health system (community, subcenter, Primary health Centre (PHC) and district hospital) Recruitment commenced in Siddipet district 6 June 2022 and will commence in Haryana 1 January 2023.


Recruitment information / eligibility

Status Recruiting
Enrollment 3240
Est. completion date December 2024
Est. primary completion date June 2024
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - For Primary health Centres: - located in the selected districts - provide pregnancy care - chief doctor (or equivalent) agrees to participate - For women >12 weeks pregnant Exclusion Criteria: - women who plan to move away and not return to the same village for the next 12 months - women unable to understand the local study language - Women who do not give consent

Study Design


Intervention

Other:
SMARThealth Pregnancy
At each visit, the CHW will: Update history and contact details Check haemoglobin with a point of care device. Check BP Check iron folic acid (IFA) supply and compliance Brief screen for mental health problems An electronic decision support platform will provide advice if referral is needed. At the Primary Health Centre, doctor/s will be issued a tablet computer with a version of the SMARThealth Pregnancy App to: Generate an automated list of all patients in the community who require review, with the dates of testing and referral, and with two-way communication back to the CHW. Suggest management based on current Indian guidelines for the diagnosis and management of anaemia, hypertension and diabetes in pregnant and non-pregnant adults.

Locations

Country Name City State
India The George Institute for Global Health Hyderabad Telangana

Sponsors (2)

Lead Sponsor Collaborator
The George Institute University of Oxford

Country where clinical trial is conducted

India, 

References & Publications (1)

Nagraj S, Kennedy SH, Jha V, Norton R, Hinton L, Billot L, Rajan E, Arora V, Praveen D, Hirst JE. SMARThealth Pregnancy: Feasibility and Acceptability of a Complex Intervention for High-Risk Pregnant Women in Rural India: Protocol for a Pilot Cluster Randomised Controlled Trial. Front Glob Womens Health. 2021 May 28;2:620759. doi: 10.3389/fgwh.2021.620759. eCollection 2021. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Differences in quality of life scores Differences in EuroQuol 5D (EQ5D) score between baseline and at 12 months 10-12 months after delivery
Other Differences in depression scores Differences in Patient Health Questionnaire 9 (PHQ9) scores between baseline and at 12 months 10-12 months after delivery
Other Differences in anxiety scores Differences in Generalised Anxiety and Depression score 7 (GAD7) scores between baseline and at 12 months 10-12 months after delivery
Other Infant feeding World Health Organization Infant and Young Feeding Assessment 6 weeks after delivery and 12 months after delivery]
Other Pregnancy intention Difference in London Measure of Unplanned pregnancy scores 10-12 months post natal
Other Cost of care Direct and indirect costs of care during pregnancy and for the first six weeks after birth 6 - 10 weeks after birth
Primary Decrease anaemia prevalence in women Proportion of participants with any degree of anaemia (non-pregnant definition Hb < 12g/dL) between the intervention and control clusters 10-12 months after delivery
Secondary Decrease the proportion of women with moderate and severe anaemia Proportion of participants with moderate anaemia (Hb < 10g /dL) and severe anaemia (Hb < 8g /dL) between the intervention and control clusters 10-12 months after delivery
Secondary Postnatal screening for type 2 diabetes after GDM Proportion of women with GDM who undergo screening for type 2 diabetes in the first year after delivery 10-12 months after delivery
Secondary Postnatal screening for hypertension after hypertensive disorder of pregnancy Proportion of women with a hypertensive disorder of pregnancy screened for hypertension in the first year after delivery 10-12 months after delivery
Secondary Compliance with iron-folic acid supplements during pregnancy and breastfeeding Self reported compliance with iron folic acid supplementation 10-12 months after delivery
Secondary De-worming treatment Proportion of women during pregnancy who receive de-worming treatment during pregnancy
Secondary Point of care Haemoglobin (Hb) testing Proportion of women who have a point of care Hb test during pregnancy and in the post natal period 10-12 months after delivery
Secondary Referral of high risk conditions The proportion of women detected with anaemia, hypertension or GDM correctly referred to primary or secondary care Six weeks post delivery
Secondary Hypertension after hypertensive disorder of pregnancy Differences in systolic and diastolic blood pressure in women who were diagnosed during pregnancy with hypertensive disorder of pregnancy 10-12 months after delivery
Secondary Dysglycaemia after a pregnancy affected by GDM Difference in HbA1c, fasting and 2-hour glucose venous samples post 75 gram glucose load in those who developed GDM during pregnancy 10-12 months after delivery
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A

External Links